Suspended NA INTERVENTIONAL 2-arm NCT03886012

Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo

Efficacy of a Transcranial Vibrating System for Mitigation of Outcomes of Migraine Associated Vertigo

Sponsor: Otolith Labs

Conditions Confusion Dizziness Headache Nausea

Updated 6 times since 2019 Last updated: Apr 23, 2021 Started: Apr 26, 2019 Primary completion: Dec 30, 2021 Completion: Dec 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

COVID-19 general concerns.

A NA clinical study on Confusion and Dizziness, this trial is suspended. The trial is conducted by Otolith Labs and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
May 2021 — Jul 2024 [monthly]

Suspended NA

Status: Recruiting → Suspended
Jan 2021 — May 2021 [monthly]

Recruiting NA
May 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Apr 2019 — May 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Otolith Labs

Data source: Otolith Labs

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States